The finding that PSD95 exhibits an aberrant redistribution from the synapse to the cell soma prior to the appearance of neuronal loss in the JNPL3 mouse model of tauopathy (54) is yet additional support for a key role of PSD95 abnormalities in driving tau-mediated neuronal dysfunction. The gene discussed is MAPT; the disease is tauopathy.